Why Reviewers Now Demand Use Error Analysis in Your CER

Hatem Rabeh

Written by HATEM RABEH, MD, MSc Ing

Your Clinical Evaluation Expert And Partner

in
S

A Notified Body sends back your clinical evaluation report with a single line: \

This scenario is becoming routine. What was once considered part of usability engineering is now appearing as a clinical evaluation requirement. Reviewers want to see use error analysis directly in your CER. Not as an attachment. Not referenced vaguely. But analyzed, discussed, and integrated into your benefit-risk assessment.

The shift is not arbitrary. It comes from a clearer interpretation of MDR Article 61 and how clinical data must include real-world use conditions. If use errors contribute to harm, they belong in your clinical evaluation. If they do not, you need to show why.

What Use Error Analysis Actually Means

Use error analysis is not a list of complaints. It is a structured review of how users interact with your device under real conditions and what happens when that interaction goes wrong.

IEC 62366 defines use error as an act or omission that results in a different response than intended by the manufacturer. The user presses the wrong button. They misinterpret a display. They skip a step. The device delivers an incorrect dose. Or no dose at all.

In usability engineering, you identify these errors during formative and summative testing. You assess risk. You implement mitigations. You document everything in your usability file.

But clinical evaluation asks a different question: what does the clinical data say about these errors in practice?

Key Insight
Use error analysis in the CER is not about repeating your usability engineering file. It is about linking usability risks to clinical outcomes and showing that your benefit-risk ratio remains favorable when use conditions are realistic.

Why This Is Becoming a Standard Request

For years, clinical evaluation and usability engineering ran on parallel tracks. The CER focused on efficacy and safety from clinical studies. The usability file focused on human factors testing and design mitigations. Reviewers looked at each file separately.

That separation no longer holds. Notified Bodies now expect integration.

The reason is simple. Real-world harm often comes from use errors, not device malfunctions. A pump delivers the correct dose when tested in the lab but is misused at the bedside. A diagnostic device produces accurate results in trained hands but fails when used by less experienced operators. The failure is not mechanical. It is contextual.

If your CER does not address this, it is incomplete. It presents a picture of performance under ideal conditions, not the conditions your users actually face.

Reviewers see this gap. They ask: where is the analysis of how users interact with the device? What errors have been observed post-market? How do those errors affect clinical outcomes? What mitigations have been validated in the field?

If your answer is

Frequently Asked Questions

What is a Clinical Evaluation Report (CER)?

A CER is a mandatory document under MDR 2017/745 that demonstrates the safety and performance of a medical device through systematic analysis of clinical data. It must be updated throughout the device lifecycle based on PMCF findings.

How often should the CER be updated?

The CER should be updated whenever significant new clinical data becomes available, after PMCF activities, when there are changes to the device or intended purpose, and at minimum during annual reviews as part of post-market surveillance.

What causes CER rejection by Notified Bodies?

Common reasons include inadequate equivalence demonstration, insufficient clinical data for claims, poorly structured SOTA analysis, missing gap analysis, and lack of clear benefit-risk determination. Structure and logical flow are as important as the data itself.

Which MDCG guidance documents are most relevant for clinical evaluation?

Key documents include MDCG 2020-5 (Equivalence), MDCG 2020-6 (Sufficient Clinical Evidence), MDCG 2020-13 (CEAR Template), MDCG 2020-7 (PMCF Plan), and MDCG 2020-8 (PMCF Evaluation Report). IEC 62366

Need Expert Help with Your Clinical Evaluation?

Get personalized guidance on MDR compliance, CER writing, and Notified Body preparation.

Peace, Hatem

Your Clinical Evaluation Partner

Follow me for more insights and practical advice.

Deepen Your Knowledge

Read Complete Guide to Clinical Evaluation under EU MDR for a comprehensive overview of clinical evaluation under EU MDR 2017/745.